Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...
Ranked by Value of LOCAL SBA loans in 12 months ended June 30, 2025 Showcase your company news with guaranteed exposure both in print and online The Dayton Business Journal's news team will provide ...
Abstract: Orthogonal Frequency Division Multiplexing with Index Modulation (OFDM-IM) is regarded as a promising candidate for next generation communications due to its remarkable efficiency and ...
Kamali_et_al_ExSEnt_Extrema-segmented_Entropy_Analysis_of_Time_Series Kamali_et_al_ExSEnt_Extrema-segmented_Entropy_Analysis_of_Time_Series Public Forked from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback